Shanghai Model Organisms Center Inc (688265) - Total Assets
Based on the latest financial reports, Shanghai Model Organisms Center Inc (688265) holds total assets worth CN¥1.90 Billion CNY (≈ $277.91 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Shanghai Model Organisms Center Inc for net asset value and shareholders' equity analysis.
Shanghai Model Organisms Center Inc - Total Assets Trend (2015–2024)
This chart illustrates how Shanghai Model Organisms Center Inc's total assets have evolved over time, based on quarterly financial data.
Shanghai Model Organisms Center Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Shanghai Model Organisms Center Inc's total assets of CN¥1.90 Billion consist of 59.5% current assets and 40.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.4% |
| Accounts Receivable | CN¥114.00 Million | 5.9% |
| Inventory | CN¥12.67 Million | 0.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥241.31 Million | 12.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Shanghai Model Organisms Center Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 688265 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Model Organisms Center Inc's current assets represent 59.5% of total assets in 2024, a decrease from 89.8% in 2015.
- Cash Position: Cash and equivalents constituted 10.4% of total assets in 2024, down from 74.0% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 4.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 12.5% of total assets.
Shanghai Model Organisms Center Inc Competitors by Total Assets
Key competitors of Shanghai Model Organisms Center Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Royalty Pharma Plc
NASDAQ:RPRX
|
USA | $19.62 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
|
China | CN¥7.26 Billion |
|
Hebei Changshan Biochem Pharma
SHE:300255
|
China | CN¥4.66 Billion |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥38.02 Billion |
|
Shanghai Junshi Biosciences Co Ltd
SHG:688180
|
China | CN¥11.69 Billion |
|
Spyre Therapeutics Inc.
NASDAQ:SYRE
|
USA | $504.60 Million |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $563.83 Million |
Shanghai Model Organisms Center Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.47 | 7.01 | 3.58 |
| Quick Ratio | 7.35 | 6.90 | 3.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥996.42 Million | CN¥931.45 Million | CN¥163.46 Million |
Shanghai Model Organisms Center Inc - Advanced Valuation Insights
This section examines the relationship between Shanghai Model Organisms Center Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.94 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | -3.4% |
| Total Assets | CN¥1.93 Billion |
| Market Capitalization | $471.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Model Organisms Center Inc's assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shanghai Model Organisms Center Inc's assets decreased by 3.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shanghai Model Organisms Center Inc (2015–2024)
The table below shows the annual total assets of Shanghai Model Organisms Center Inc from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.93 Billion ≈ $282.33 Million |
-3.42% |
| 2023-12-31 | CN¥2.00 Billion ≈ $292.34 Million |
-2.72% |
| 2022-12-31 | CN¥2.05 Billion ≈ $300.52 Million |
+4.56% |
| 2021-12-31 | CN¥1.96 Billion ≈ $287.40 Million |
+450.13% |
| 2020-12-31 | CN¥357.02 Million ≈ $52.24 Million |
+63.25% |
| 2019-12-31 | CN¥218.70 Million ≈ $32.00 Million |
+14.09% |
| 2018-12-31 | CN¥191.68 Million ≈ $28.05 Million |
+7.33% |
| 2017-12-31 | CN¥178.59 Million ≈ $26.13 Million |
+18.49% |
| 2016-12-31 | CN¥150.72 Million ≈ $22.05 Million |
+35.59% |
| 2015-12-31 | CN¥111.16 Million ≈ $16.27 Million |
-- |
About Shanghai Model Organisms Center Inc
Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. The company uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. It offers toolbox of mice; disease mice, such as rare, infectious, a… Read more